Just in the previous years, researchers have realized the huge role that the microorganisms living inside and on us play in our health. The human microbiome, and specifically the gut microbiome, has been linked to several persistent illness, including diabetes. An out of balance microbiome structure has been found in patients with diabetes, who tend to have a less varied gut microbiome as compared to healthy individuals. Dimensions Of.
Some companies are establishing diabetes treatments targeting the microbiome. The French Valviotis is presently performing preclinical testing of a drug aimed at increasing the microbiome diversity as a treatment for type 2 diabetes. Although appealing, the microbiome field is extremely young and its intricacy makes it difficult to develop causation after discovering correlation.
That world may not be so far away, as numerous companies are developing non-invasive techniques to replace finger pricking. Dimensions Of. Stability Applications has actually established a device called GlucoTrack that can measure glucose utilizing electromagnetic waves and is already available in Europe. Comparable innovations are popping up, with GlucoSense in London utilizing laser light to determine sugar levels and MediWise making use of radio waves.
The GlucoWise sensing unit prototypePatches are likewise becoming a popular form of determining blood sugar without needles, such as FreeStyle Libre, an inch-wide spot that can be worn for up to 2 weeks. At the University of Bath, researchers are developing a graphene spot that might supply greater precision by determining sugar levels separately in multiple hair roots – Dimensions Of.
On the other hand, Senseonic and Roche are dealing with a gadget that is implanted under the skin. Dimensions Of. Still, non-invasive options to measure blood glucose frequently deal with concerns relating to precision. The well-known glucose-measuring contact lens that Google announced in 2014 was dismissed as “technically infeasible” and further advancements will be required to reach the degree of precision of finger-pricking approaches.
Scientists are already hypothesizing about microchips that can detect diabetes type 1 before the signs appear or nanorobots traveling in the bloodstream while they determine glucose and provide insulin – Dimensions Of.”There’s little fiction left in this. I strongly believe that microrobotics will come and will belong to our drug shipment within the next ten years,” said Tomas Landh, Director of Strategy and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Annual MeetingWhatever the future brings, it will undoubtedly make a substantial difference in the lives of countless people worldwide.